Let's look at why this news could be a game-changer for Eli Lilly and its stock.

In December, Novo Nordisk reported that CagriSema helped patients lose, on average, 22.7% of their body weight ... versus other GLP-1 leaders, sent Novo Nordisk's stock price down by about 20% ...

The BSE Sensex slipped below 79,000 briefly, and was later trading at 79,054.95, down 746.48 points, or 0.94 per cent. Nifty ...